The global Intradermal Injection Market is expected to exceed an impressive valuation of US$ 3,878 Million in 2022, with a compound annual growth rate (CAGR) of 10.8% projected from 2022 to 2032.

The global Intradermal Injection market size was estimated to be US$ 3.3 billion in 2021 and is expected grow at a CAGR of 10.5% between 2023 to 2032. Intradermal injection is the process of injecting ...

PharmaJet's Needle-free Tropis is being evaluated in a clinical study by REDE-TB as a potential improvement on the TB skin ...

PharmaJet (R) , a company focused on improving the performance and outcomes of injectables through needle-free injection technology, announced that its partner, Brazilian Tuberculosis Research Network ...

The patch-testing outfits were supplied through the courtesy of the Lederle Laboratories, Incorporated, Pearl River, New York.

COSA MESA, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company, announced the receipt of FDA clearance for testing AIV001 (axitinib) by intradermal ...

GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company that has developed and commercialized a needle-free platform to more effectively administer drugs and biologics, today announced they received an ...

LAVAL, Quebec--(BUSINESS WIRE)--Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, ...

PharmaJet® to Highlight the Benefits of Intradermal Needle-free Delivery and Expansion into the Self-Injection Pen Market at Upcoming PODD Conference PharmaJet will deliver two presentations on ...

The Institute for Science and Technology (IWT) has granted €250,000 to Novosanis, a company designs and develops medical devices for a variety of applications, in support of an SME innovation project ...